Sessa Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-108,000
Closed -$6.78M 33
2022
Q1
$6.78M Buy
+108,000
New +$6.78M 0.32% 27